Shin JE, Park S, Jung HA, Sun JM, et al. Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study. BMC Cancer 2025;25:1616.
PMID: 41121006